<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rdf.xsl"?>
<rdf:RDF  xmlns="http://purl.org/rss/1.0/"
				  xmlns:dc="http://purl.org/dc/elements/1.1/
					xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
					
<channel rdf:about="http://livepress.com">
          <title>Eli Lilly			
 - livepress.com</title>
      <link>http://Eli Lilly			
.livepress.com</link>
      <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
  <dc:publisher>livepress.com</dc:publisher>
  <dc:creator>livepress.com</dc:creator>
  <dc:rights>Copyright &#169; 2006 livepress.com</dc:rights>
  <sy:updatePeriod>hourly</sy:updatePeriod>
  <sy:updateFrequency>2</sy:updateFrequency>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://livepress.com" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://livepress.com/go/?127869">
  		<title><![CDATA[State of Mississippi Files Lawsuit Against Eli Lilly and Company Over Zyprexa]]></title>
	  	<link>http://livepress.com/go/?127869</link>
  		  		<dc:description><![CDATA[   Mississippi Attorney General Jim Hood has filed a lawsuit against  Eli Lilly  and Company for claims arising from Lilly&#8217;s sale and marketing of its antipsychotic prescription drug, Zyprexa&#38;reg;. The suit was filed in the State Circuit Court of Lafayette County, according to State of Mississippi Special Assistant Attorney General Tim Balducci of the Langston Law Firm in Booneville, Miss. 

                        

      ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?124584">
  		<title><![CDATA[Eli Lilly And Co. 2Q Earnings Skyrocket]]></title>
	  	<link>http://livepress.com/go/?124584</link>
  		  		<dc:description><![CDATA[Pharmaceutical company  Eli Lilly  and Co. on Friday said its second-quarter earnings rose as the company generated more revenue from newer drugs. Lilly also noted that Cymbalta, its depression treatment drug, witnessed stronger sales in the quarter....]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?124262">
  		<title><![CDATA[Lilly reports strong earnings, after year-ago loss 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?124262</link>
  		  		<dc:description><![CDATA[    Reuters -  Eli Lilly  and Co.  on Friday 
reported strong second-quarter earnings, fueled by strong 
revenue growth of newer drugs, including an almost doubling of 
sales for its Cymbalta depression treatment.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?122953">
  		<title><![CDATA[U.S. approves drug for ovarian cancer, spurns panel 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?122953</link>
  		  		<dc:description><![CDATA[Reuters - The U.S. Food and Drug Administration 
approved the drug Gemzar for treating recurrent ovarian  cancer , 
ignoring the advice given by an FDA panel earlier this year 
that had strongly recommended against approval,  Eli Lilly  and 
Co., the drug maker, said Monday.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?118239">
  		<title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?118239</link>
  		  		<dc:description><![CDATA[AP - Drug companies are racing to capture the ballooning market in  diabetes  care.  Pfizer  Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and  Eli Lilly  and Co. are awaiting FDA approval for new  diabetes  products that could generate hundreds of millions of dollars in sales.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?104511">
  		<title><![CDATA[Drug shown to cut diabetics' vision loss 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?104511</link>
  		  		<dc:description><![CDATA[AP - An experimental  Eli Lilly  and Co. drug reduced vision loss in diabetics by inhibiting an enzyme that damages the eye's light-sensing retina, according to the results of two clinical trials.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?103991">
  		<title><![CDATA[Lilly drug helps reduce diabetic vision loss: study 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?103991</link>
  		  		<dc:description><![CDATA[Reuters - An experimental drug by  Eli Lilly  and 
Co.  showed promise in reducing vision loss caused by 
the effects of  diabetes  on the retina, according to combined 
data from a pair of late-stage clinical trials presented on 
Sunday.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?85269">
  		<title><![CDATA[Barr says Lilly sues to stop generic weekly Prozac 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?85269</link>
  		  		<dc:description><![CDATA[Reuters - Barr  Pharmaceuticals  Inc.  on 
Thursday said  Eli Lilly  & Co.  has sued the company, 
claiming Barr's generic weekly form of anti-depressant Prozac 
infringes the patent on Lilly's branded medicine.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?82436">
  		<title><![CDATA[Ariad's Shares Climb 40 Percent After It Wins Patent Case]]></title>
	  	<link>http://livepress.com/go/?82436</link>
  		  		<dc:description><![CDATA[ Ariad  Pharmaceuticals  Inc. shares climbed up to 40 percent on Thursday after the company announced it won a patent infringement case against  Eli Lilly  and Co.
 Reuters reports a federal court in Massachusetts decided that Lilly's osteoporosis...]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?72458">
  		<title><![CDATA[Schering-Plough, Merck impress, Lilly disappoints 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?72458</link>
  		  		<dc:description><![CDATA[Reuters - Stellar sales of their shared 
cholesterol drugs spurred  Schering-Plough  Corp. and  Merck  & Co. 
to better-than-expected quarterly results on Thursday, but 
investors were disappointed by  Eli Lilly  and Co. as sales of 
its biggest product continued to slide.]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?72110">
  		<title><![CDATA[Eli Lilly first quarter profit rises 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?72110</link>
  		  		<dc:description><![CDATA[    Reuters -  Eli Lilly  and Co.  on Thursday 
reported higher first-quarter profit as price increases helped 
offset the impact of declining sales of some of its most 
important drugs.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?70491">
  		<title><![CDATA[New Cancer Drug Shows Fewer Side Effects 
    (AP)
]]></title>
	  	<link>http://livepress.com/go/?70491</link>
  		  		<dc:description><![CDATA[    AP - Women at high risk of breast cancer after menopause often shun a protective drug for fear of side effects. Now a striking study shows a widely used bone drug prevents breast cancer, too &amp;#151; a safer yet equally effective alternative to that old standby tamoxifen.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?70300">
  		<title><![CDATA[Evista as good as tamoxifen for breast cancer: study 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?70300</link>
  		  		<dc:description><![CDATA[    Reuters - The osteoporosis drug Evista works 
as well as tamoxifen in reducing the risk of  breast cancer  in 
high-risk older women, with fewer dangerous side effects, 
researchers said on Monday.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?70239">
  		<title><![CDATA[Osteoporosis Drug Cuts Breast Cancer Risk]]></title>
	  	<link>http://livepress.com/go/?70239</link>
  		  		<dc:description><![CDATA[  Eli Lilly  and Co's Evista osteoporosis drug works as well as the older tamoxifen in reducing the risk of  breast cancer  in high-risk women, with fewer dangerous side effects, researchers said on Monday. 
 The results of the 19,000-woman...]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?70108">
  		<title><![CDATA[Lilly bone drug cuts breast cancer risk: study 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?70108</link>
  		  		<dc:description><![CDATA[    Reuters -  Eli Lilly  and Co&#039;s Evista 
osteoporosis drug works as well as the older tamoxifen in 
reducing the risk of  breast cancer  in high-risk women, with 
fewer dangerous side effects, researchers said on Monday.  ]]></dc:description>
  				</item>
<item rdf:about="http://livepress.com/go/?70104">
  		<title><![CDATA[Lilly drug cuts breast cancer risk, fewer side-effects 
    (Reuters)
]]></title>
	  	<link>http://livepress.com/go/?70104</link>
  		  		<dc:description><![CDATA[    Reuters - Evista,  Eli Lilly  and Co&#039;s 
osteoporosis drug, works just as well as the older drug 
tamoxifen in reducing the risk of  breast cancer  in high-risk 
women, and without some of the dangerous side-effects, 
researchers said on Monday.  ]]></dc:description>
  				</item>
</rdf:RDF>